.svg){kind=small}
Jun-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
Attune’s category mix in June 2026 is fully concentrated in Topical, with 100.0% share, while brand sales declined 13.43% year over year and fell 28.70% month over month. Within Topical, average price decreased 7.21% YoY, and the brand’s 24‑month sales are up 32.91%, indicating a longer-cycle expansion despite the June pullback. The pattern implies a single-category dependence that amplified the 28.70% MoM volatility and translated the 7.21% YoY price compression directly into a 13.43% YoY sales contraction.
Positionally, ranking 3 in Massachusetts Topical in June 2026 alongside a 13.43% YoY sales decline and a 7.21% YoY price drop suggests the brand traded price for retention while ceding some velocity. With 100.0% of sales in Topical and a 28.70% MoM decline, the lack of mix diversification increased exposure to monthly demand swings; the 32.91% 24‑month growth indicates prior share gains that are now sensitive to pricing strategy. The implication is that maintaining rank 3 will likely require either restoring price realization or adding a second category to dampen Topical-driven swings.
Competitive Landscape
Attune is ranked #3 in June 2026 in MA Topical, unchanged YoY from #3, after slipping two positions from its peak of #2 in April 2026 to #3 by June 2026. In the same period, Chill Medicated held #2 with a 19.3% YoY sales increase while Attune ceded the #2 spot from April 2026 to June 2026, and Treeworks remained #1 with a 17.5% YoY lift, indicating Attune’s stability at #3 coincides with upward pressure from faster-growing incumbents. Meanwhile, Sanctuary Medicinals advanced from #9 YoY to #4 in June 2026 with a 92.9% YoY sales surge, and Doctor Solomon's stayed at #5 with a 33.7% YoY decline, implying Attune’s flat YoY rank masks share risk as momentum consolidates above and a fast-rising challenger approaches from below.
Notable Products
CBD/THC 1:1 Muscle Freeze Lotion (50mg CBD, 50mg THC) posted the steepest decline at -70.5% MoM and slid to rank 4, while CBD/THC 1:1 Muscle Freeze (69mg CBD, 66mg THC) fell -40.7% to rank 3. The leading CBD/THC 1:1 Muscle Freeze Lotion (75mg CBD, 75mg THC) held rank 1 with a -2.9% MoM dip and approximately $11,290 in June 2026 sales, as Muscle Freeze Lotion (100mg THC, 30ml) dropped -49.3% to rank 2. With five of the top ten concentrated in Topical SKUs and three 1:1 formulations diverging in momentum, the pattern implies dependency on a single flagship while the broader Muscle Freeze line is contracting and may need SKU rationalization or price-pack adjustments.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
